Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Approaches To Innovation Needed To Reach Globe's Poor At The "Bottom Of The Pyramid" - And To Fend Off Emerging Competitors Around The World

This article was originally published in PharmAsia News

Executive Summary

CAMBRIDGE, Mass. - Life science companies looking to provide healthcare solutions to the poorer, "bottom of the pyramid" - a population reaching more than 600 million people in India alone - should focus on business model innovation as much as on innovative products, according to delegates at the U.S.-India Chamber of Commerce biopharmaceutical and healthcare summit in Cambridge, Mass

You may also be interested in...



Green Shoots Of Health Care Delivery In India’s Neglected Northeast

India’s northeast combines a rural population that lacks access to basic health care in many cases in terrain dissected by rivers, jungles and mountains. The World Bank has identified funding several models of sustainable and scalable health care delivery for start-ups that transcend such barriers.

Pharma Innovation Increasingly Viable In Middle-Income Countries

R&D spending grew 455% among PhRMA members in Asia between 2005 and 2010, compared to increases of 112% in Latin America and 303% in India, according to IFPMA survey.

Pharma’s Aim: Tap Innovation In Emerging Markets To Fix Woes At Home (Part 2 of 2)

Pharma must learn how to apply the best of its experiences in emerging markets to its traditional business, or, experts warn, invigorated competition from more nimble, faster-growing local players that have enjoyed success on their own turf will become a global threat.

Related Content

UsernamePublicRestriction

Register

OM005224

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel